ChemPartner PharmaTech Co (300149.SZ) Stock Price

ChemPartner PharmaTech Co Price

CLOSED
11.35CNY+1.00 (+9.22 %)
Market closed

Over the last 17 years ChemPartner PharmaTech Co grew revenue by 17.2% annually, reaching 970.20 M CNY. Earnings per share have grown at 5.7% per year over the last 15 years. For ChemPartner PharmaTech Co, the net margin of -23.3% is down versus 10.4% a few years ago. At today's price the dividend yield works out to roughly 0.62%. The dividend has grown at 0.4% per year over the past 10 years. The stock trades about 54% above its 52-week low.

ChemPartner PharmaTech Co stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of ChemPartner PharmaTech Co over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how ChemPartner PharmaTech Co stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing ChemPartner PharmaTech Co's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

ChemPartner PharmaTech Co Stock Price History
DateChemPartner PharmaTech Co Price
8/20/202611.35 CNY
8/19/202610.35 CNY
8/18/202610.77 CNY
8/17/202611.08 CNY
8/14/202611.16 CNY
8/13/202611.34 CNY
8/12/202611.04 CNY
8/11/202611.07 CNY
8/10/202610.48 CNY
8/7/202610.42 CNY
8/6/20269.69 CNY
8/5/20269.65 CNY
8/4/20269.52 CNY
8/3/20269.11 CNY
7/31/20268.95 CNY
7/30/20268.66 CNY
7/29/20268.94 CNY
7/28/20269.25 CNY
7/27/20269.34 CNY
7/24/20268.55 CNY
7/23/20269.56 CNY
7/22/20269.73 CNY
7/21/20269.74 CNY
7/20/202610.18 CNY
7/17/20269.82 CNY
7/16/202611.09 CNY
7/15/202610.39 CNY
7/14/20268.66 CNY
7/13/20268.64 CNY
7/10/20268.95 CNY
7/9/20268.45 CNY
7/8/20268.78 CNY
7/7/20268.88 CNY
7/6/20269.45 CNY
7/3/20269.53 CNY
7/2/20269.46 CNY
7/1/20269.90 CNY
6/30/20269.54 CNY
6/29/20269.86 CNY
6/26/20268.50 CNY
6/25/20269.11 CNY
6/24/20269.01 CNY
6/23/20269.14 CNY
6/22/20267.37 CNY
6/18/20267.70 CNY
6/17/20267.57 CNY
6/16/20267.72 CNY
6/15/20267.77 CNY
6/12/20267.90 CNY
6/11/20267.62 CNY
6/10/20267.84 CNY
6/9/20267.92 CNY
6/8/20267.92 CNY
6/5/20268.25 CNY
6/4/20268.16 CNY
6/3/20268.28 CNY
6/2/20268.32 CNY
6/1/20268.60 CNY
5/29/20268.38 CNY
5/28/20268.44 CNY
5/27/20268.38 CNY
5/26/20268.53 CNY
5/25/20268.81 CNY
5/22/20268.99 CNY
5/21/20269.32 CNY
5/20/20269.34 CNY
5/19/20269.38 CNY
5/18/20269.40 CNY
5/15/20269.44 CNY
5/14/20269.53 CNY
5/13/20269.83 CNY
5/12/20269.90 CNY
5/11/202610.14 CNY
5/8/202610.05 CNY
5/7/20269.98 CNY
5/6/202610.02 CNY
4/30/20269.99 CNY
4/29/202610.00 CNY
4/28/202610.60 CNY
4/27/202610.50 CNY
4/24/202610.57 CNY
4/23/202610.66 CNY
4/22/202610.96 CNY
4/21/202610.81 CNY
4/20/202611.18 CNY
4/17/202611.09 CNY
4/16/202611.42 CNY
4/15/202611.59 CNY
4/14/202611.25 CNY
4/13/202611.04 CNY
4/10/202611.20 CNY
4/9/202611.28 CNY
4/8/202611.67 CNY
4/7/202611.66 CNY
4/3/202612.02 CNY
4/2/202612.74 CNY
4/1/202612.42 CNY
3/31/202610.35 CNY
3/30/202610.36 CNY
3/27/202610.27 CNY
3/26/20269.68 CNY
3/25/20269.78 CNY
3/24/20269.73 CNY
3/23/20269.10 CNY
3/20/20269.62 CNY
3/19/20269.92 CNY
3/18/202610.23 CNY
3/17/202610.09 CNY
3/16/202610.20 CNY
3/13/202610.14 CNY
3/12/202610.11 CNY
3/11/202610.32 CNY
3/10/202610.48 CNY
3/9/202610.15 CNY
3/6/202610.41 CNY
3/5/202610.20 CNY
3/4/20269.84 CNY
3/3/20269.96 CNY
3/2/202610.35 CNY
2/27/202610.81 CNY
2/26/202610.67 CNY
2/25/202610.81 CNY
2/24/202610.92 CNY
2/13/202610.99 CNY
2/12/202611.10 CNY
2/11/202611.16 CNY
2/10/202611.28 CNY
2/9/202611.02 CNY
2/6/202610.85 CNY
2/5/202610.90 CNY
2/4/202611.01 CNY
2/3/202610.84 CNY
2/2/202610.47 CNY
1/30/202610.44 CNY
1/29/202610.69 CNY
1/28/202610.72 CNY
1/27/202611.03 CNY
1/26/202611.23 CNY
1/23/202611.30 CNY
1/22/202610.71 CNY
1/21/202610.82 CNY
1/20/202610.80 CNY
1/19/202611.02 CNY
1/16/202611.30 CNY
1/15/202612.07 CNY
1/14/202612.35 CNY
1/13/202612.69 CNY
1/12/202612.61 CNY
1/9/202610.95 CNY
1/8/202610.61 CNY
1/7/202610.12 CNY
1/6/202610.04 CNY
1/5/202610.11 CNY
12/31/20259.56 CNY
12/30/20259.57 CNY
12/29/20259.62 CNY
12/26/20259.68 CNY
12/25/20259.82 CNY
12/24/20259.77 CNY
12/23/20259.72 CNY
12/22/20259.83 CNY
12/19/20259.81 CNY
12/18/20259.60 CNY
12/17/20259.45 CNY
12/16/20259.48 CNY
12/15/20259.61 CNY
12/12/20259.82 CNY
12/11/20259.82 CNY
12/10/20259.98 CNY
12/9/202510.00 CNY
12/8/20259.99 CNY
12/5/20259.89 CNY
12/4/20259.87 CNY
12/3/20259.86 CNY
12/2/202510.12 CNY
12/1/202510.32 CNY
11/28/202510.39 CNY
11/27/202510.40 CNY
11/26/202510.42 CNY
11/25/202510.35 CNY
11/24/202510.28 CNY
11/21/202510.11 CNY
11/20/202510.61 CNY
11/19/202510.87 CNY
11/18/202511.15 CNY
11/17/202511.25 CNY
11/14/202511.67 CNY
11/13/202511.25 CNY
11/12/202510.93 CNY
11/11/202511.04 CNY
11/10/202510.91 CNY
11/7/202510.82 CNY
11/6/202511.00 CNY
11/5/202511.15 CNY
11/4/202511.22 CNY
11/3/202511.63 CNY
10/31/202511.59 CNY
10/30/202511.07 CNY
10/29/202511.63 CNY
10/28/202511.49 CNY
10/27/202511.59 CNY
10/24/202511.30 CNY
10/23/202511.30 CNY
10/22/202511.52 CNY
10/21/202511.43 CNY
10/20/202511.25 CNY
10/17/202511.23 CNY
10/16/202511.63 CNY
10/15/202511.71 CNY
10/14/202511.05 CNY
10/13/202511.30 CNY
10/10/202511.51 CNY
10/9/202511.72 CNY
9/30/202511.41 CNY
9/29/202511.50 CNY
9/26/202511.41 CNY
9/25/202512.04 CNY
9/24/202511.99 CNY
9/23/202511.95 CNY
9/22/202512.60 CNY
9/19/202512.69 CNY
9/18/202513.00 CNY
9/17/202513.44 CNY
9/16/202513.94 CNY
9/15/202513.97 CNY
9/12/202513.40 CNY
9/11/202512.95 CNY
9/10/202513.20 CNY
9/9/202513.14 CNY
9/8/202513.75 CNY
9/5/202513.18 CNY
9/4/202513.17 CNY
9/3/202512.62 CNY
9/2/202512.94 CNY
9/1/202513.15 CNY
8/29/202512.73 CNY
8/28/202512.36 CNY
8/27/202512.39 CNY
8/26/202512.93 CNY
8/25/202513.42 CNY
Access this data via the Eulerpool API
Get Free API Key

ChemPartner PharmaTech Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2017
275.40 M CNY
52.90 M CNY
57.80 M CNY
Jan 1, 2018
996.90 M CNY
189.80 M CNY
161.10 M CNY
Jan 1, 2019
1.33 B CNY
189.70 M CNY
138.90 M CNY
Jan 1, 2020
1.48 B CNY
277.90 M CNY
154.60 M CNY
Jan 1, 2021
1.69 B CNY
82.29 M CNY
-402.25 M CNY
Jan 1, 2022
1.33 B CNY
-266.54 M CNY
362.63 M CNY
Jan 1, 2023
1.14 B CNY
-75.42 M CNY
-916.75 M CNY
Jan 1, 2024
970.20 M CNY
-87.67 M CNY
-226.47 M CNY

ChemPartner PharmaTech Co Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 22, 2026, 3:40 AM
 
REVENUEB CNY
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM CNY
EBITM CNY
EBIT MARGIN%
NET INCOMEM CNY
NET INCOME GROWTH%
DIV.CNY
DIV. GROWTH%
SHARESM
2009201020112012201320142015201620172018201920202021202220232024
0.100.120.170.240.260.280.320.260.281.001.331.481.691.331.140.97
3.0923.0034.9643.377.569.7713.17-18.876.59262.1833.2311.6114.11-21.54-14.18-14.76
51.0046.3433.1339.5041.4147.6948.7450.3945.4542.7737.8338.1531.4824.7424.6020.82
51.0057.0055.0094.00106.00134.00155.00130.00125.00426.00502.00565.00532.00328.00280.00202.00
35.0036.0023.0037.0031.0041.0061.0068.0052.00189.00189.00277.0082.00-266.00-75.00-87.00
35.0029.2713.8615.5512.1114.5919.1826.3618.9118.9814.2418.704.85-20.06-6.59-8.97
29.0033.0027.0035.0039.0040.0059.0065.0057.00161.00138.00154.00-402.00362.00-916.00-226.00
26.0913.79-18.1829.6311.432.5647.5010.17-12.31182.46-14.2911.59-361.04-190.05-353.04-75.33
––0.040.040.050.060.060.100.050.040.07–0.07–––
––––25.0020.00–66.67-50.00-20.0075.00–––––
283.50315.00422.10422.10422.10422.10422.10422.10422.10460.20499.80499.80496.60497.96497.96497.96
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales ChemPartner PharmaTech Co generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue ChemPartner PharmaTech Co retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare ChemPartner PharmaTech Co's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares ChemPartner PharmaTech Co has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against ChemPartner PharmaTech Co's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

ChemPartner PharmaTech Co stock margins

The ChemPartner PharmaTech Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of ChemPartner PharmaTech Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for ChemPartner PharmaTech Co.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2017
45.61 %
19.21 %
20.99 %
Jan 1, 2018
42.80 %
19.04 %
16.16 %
Jan 1, 2019
37.83 %
14.29 %
10.46 %
Jan 1, 2020
38.15 %
18.76 %
10.43 %
Jan 1, 2021
31.50 %
4.87 %
-23.79 %
Jan 1, 2022
24.80 %
-20.09 %
27.34 %
Jan 1, 2023
24.63 %
-6.63 %
-80.53 %
Jan 1, 2024
20.88 %
-9.04 %
-23.34 %

ChemPartner PharmaTech Co Stock Revenue, EBIT, Earnings per Share

The ChemPartner PharmaTech Co earnings per share therefore indicates how much revenue ChemPartner PharmaTech Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2017
0.65 CNY
0.13 CNY
0.14 CNY
Jan 1, 2018
2.17 CNY
0.41 CNY
0.35 CNY
Jan 1, 2019
2.66 CNY
0.38 CNY
0.28 CNY
Jan 1, 2020
2.96 CNY
0.56 CNY
0.31 CNY
Jan 1, 2021
3.40 CNY
0.17 CNY
-0.81 CNY
Jan 1, 2022
2.66 CNY
-0.54 CNY
0.73 CNY
Jan 1, 2023
2.29 CNY
-0.15 CNY
-1.84 CNY
Jan 1, 2024
1.95 CNY
-0.18 CNY
-0.45 CNY

ChemPartner PharmaTech Co business model & stock analysis

ChemPartner PharmaTech Co Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

ChemPartner PharmaTech Co historical P/E ratio, EBIT multiple, and P/S ratio

ChemPartner PharmaTech Co annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

ChemPartner PharmaTech Co shares outstanding

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2017
422.10 M Stocks
Jan 1, 2018
460.20 M Stocks
Jan 1, 2019
499.80 M Stocks
Jan 1, 2020
499.80 M Stocks
Jan 1, 2021
496.60 M Stocks
Jan 1, 2022
497.96 M Stocks
Jan 1, 2023
497.96 M Stocks
Jan 1, 2024
497.96 M Stocks

ChemPartner PharmaTech Co stock splits

In ChemPartner PharmaTech Co's history, there have been no stock splits.

ChemPartner PharmaTech Co Dividend History

10 years of dividend payments · 2 consecutive increases

YearAnnual DividendYoY ChangePayments
20210.07CNY↑ 0.3%1×
20190.07CNY↑ 75.0%1×
20180.04CNY↓ 20.0%1×
20170.05CNY 0.0%1×
20160.05CNY↑ 75.0%1×
20150.03CNY↓ 28.6%1×
20140.04CNY↓ 20.0%1×
20130.05CNY↑ 25.0%1×
20120.04CNY↓ 40.7%1×
20110.07CNY—1×

ChemPartner PharmaTech Co dividend payout ratio

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2017
35.71 %
Jan 1, 2018
11.43 %
Jan 1, 2019
25.00 %
Jan 1, 2020
24.05 %
Jan 1, 2021
-8.67 %
Jan 1, 2022
20.16 %
Jan 1, 2023
23.07 %
Jan 1, 2024
22.43 %
Price targets and forecasts for ChemPartner PharmaTech Co are not yet available.

ChemPartner PharmaTech Co shareholder structure

% Name
13.74433%
Beihai Baben Venture Capital Co., Ltd.
Beihai Baben Venture Capital Co., Ltd.
5.25854%
Liang (Yufeng)
Liang (Yufeng)
5.02044%
Yu (Xianwen)
Yu (Xianwen)
4.56084%
Mega Star Centre Limited
Mega Star Centre Limited
3.27195%
Shanghai Ruijun Enterprise Management Center (LP)
Shanghai Ruijun Enterprise Management Center (LP)
2.56149%
Zeng (Xianjing)
Zeng (Xianjing)

ChemPartner PharmaTech Co Executives and Management Board

8 members · avg. age 55 · 13 % women

YZ

Mr. Yinqun Zha (46)

Chief Financial Officer

1.62 M CNY

Management

SW

Mr. Swee Lian Woo (64)

Chairman of the Board, Chief Executive Officer · since 2021

1.20 M CNY
WC

Mr. Wanglong Chen (53)

Vice President, Director · since 2023

1.01 M CNY

Board of Directors

JX

Mr. Jian Xu (41)

Secretary of the Board

1.51 M CNY
SF

Mr. Shixin Fan (60)

Staff Elected Director · since 2021

1.10 M CNY
ZG

Mr. Zhicheng Guo (63)

Independent Director

80,000.00 CNY
XW

Mr. Xianzhong Wang (55)

Independent Director

80,000.00 CNY
XZ

Ms. Xuemei Zhang (54)

Independent Director

10,000.00 CNY

ChemPartner PharmaTech Co Supply Chain

ChemPartner PharmaTech Co Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
1 companies
#NameTrend
1
HKEX
Supplier·Customer·Capital Markets·HK
0.13
0.33
0.79
0.72
0.75
-0.20

Frequently asked questions about ChemPartner PharmaTech Co

5 analysts currently rate the ChemPartner PharmaTech Co stock: 4 recommend buying, 1 holding and 0 selling.

ChemPartner PharmaTech Co Analyst Price Targets 2026

Converted at the current exchange rate, the ChemPartner PharmaTech Co share trades at 1.44 EUR (11.35 CNY).

No history available for ChemPartner PharmaTech Co.

The revenue cannot currently be calculated for ChemPartner PharmaTech Co.

The profit cannot currently be calculated for ChemPartner PharmaTech Co.

The P/E ratio cannot be calculated for ChemPartner PharmaTech Co at the moment.

The P/S cannot be calculated for ChemPartner PharmaTech Co currently.

The Eulerpool Quality Score for ChemPartner PharmaTech Co is 2/10.

The ISIN of ChemPartner PharmaTech Co is CNE100000Y27. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of ChemPartner PharmaTech Co is 300149.SZ. The ticker symbol is used to trade ChemPartner PharmaTech Co shares on the stock exchange.

The current dividend yield of ChemPartner PharmaTech Co is 0.62 %.

ChemPartner PharmaTech Co pays a dividend, distributed in the months of , , , .

ChemPartner PharmaTech Co paid dividends every year for the past 0 years.

ChemPartner PharmaTech Co is assigned to the 'Health' sector.

To receive the latest dividend of ChemPartner PharmaTech Co from amounting to 0.07 CNY, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

The dividends of ChemPartner PharmaTech Co are distributed in CNY.

All fundamentals and in-depth analysis of ChemPartner PharmaTech Co

Our stock analysis for ChemPartner PharmaTech Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ChemPartner PharmaTech Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

ChemPartner PharmaTech Co Stock
ChemPartner PharmaTech Co Revenue→
ChemPartner PharmaTech Co Stock
ChemPartner PharmaTech Co Net Income→
ChemPartner PharmaTech Co Stock
ChemPartner PharmaTech Co P/E→
ChemPartner PharmaTech Co Stock
ChemPartner PharmaTech Co P/S→
ChemPartner PharmaTech Co Stock
ChemPartner PharmaTech Co EBIT→
ChemPartner PharmaTech Co Stock
ChemPartner PharmaTech Co Dividend→
ChemPartner PharmaTech Co Stock
ChemPartner PharmaTech Co Directors Dealings→
ChemPartner PharmaTech Co Stock
ChemPartner PharmaTech Co Stocks→
ChemPartner PharmaTech Co Stock
ChemPartner PharmaTech Co Market capitalization→
ChemPartner PharmaTech Co Stock
ChemPartner PharmaTech Co Debt→
ChemPartner PharmaTech Co Stock
ChemPartner PharmaTech Co Liabilities→
ChemPartner PharmaTech Co Stock
ChemPartner PharmaTech Co Equity→
ChemPartner PharmaTech Co Stock
ChemPartner PharmaTech Co AAQS→
ChemPartner PharmaTech Co Stock
ChemPartner PharmaTech Co Employees→
ChemPartner PharmaTech Co Stock
ChemPartner PharmaTech Co ROE→
ChemPartner PharmaTech Co Stock
ChemPartner PharmaTech Co ROA→
ChemPartner PharmaTech Co Stock
ChemPartner PharmaTech Co ROCE→
ChemPartner PharmaTech Co Stock
ChemPartner PharmaTech Co News→
ChemPartner PharmaTech Co Stock
ChemPartner PharmaTech Co Analyst Price Targets→

Health Stocks

Chengda Pharmaceuticals CoChemometec A/SChengdu Easton Biopharmaceuticals CoChemomab Therapeutics Ltd DRCChengdu huasun technology group Inc LTDChemedChengdu Kanghong Pharmaceutical Group CoChemclin Diagnostics CoChengdu Kanghua Biological Products CoCheckpoint TrendsChengdu Olymvax BiopharmaceuticalsCheck CapAll Stocks A–Z →